Disturbances of antimicrobial lipids in atopic dermatitis

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 2, 2006, Pages 114-123

  Melnik, Bodo ^a,b  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

^b NONE   (Germany)

Author keywords

Antimicrobial lipids; Antimicrobial peptides; Atopic dermatitis; Cutaneous antimicrobial defense; Regulatory T cells; Sphingosines; Staphylococcus aureus

Indexed keywords

HYDROXYSPHINGANINE; SPHINGANINE; SPHINGOSINE; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; CERAMIDE; DEFB4 PROTEIN, HUMAN; FATTY ACID;

ATOPIC DERMATITIS; CELL PROLIFERATION; DISEASE PREDISPOSITION; HUMAN; NONHUMAN; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRATUM CORNEUM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ARTICLE; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN;

ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CERAMIDES; DERMATITIS, ATOPIC; FATTY ACIDS; HUMANS; SKIN; SPHINGOSINE; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 33645226857     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05902.x     Document Type: Review

References (75)

1. Schade H, Marchionini A. Der Säuremantel der Haut. Klin Wochenschr 1928; 7: 12-14.
2. Burtenshaw JML. The mechanism of self-disinfection of the human skin and its appendages. J Hyg 1942; 42: 184-210.
3. Marples RR, Downing DT, Kligman AM. Control of free fatty acids in human surface lipids by Corynebacterium acnes. J Invest Dermatol 1971; 56: 127-132.
4. Kearney JN, Ingham E, Cunliffe WJ, Holland KT. Correlations between human skin bacteria and skin lipids. Br J Dermatol 1984; 110: 593-599.
5. Kellum RE. Human sebaceous gland lipids: analysis by thin-layer chromatography. Arch Dermatol 1967; 95: 218-220.
6. Miller SJ, Aly R, Shinefield HR, Elias PM. In vitro and in vivo anti-staphylococcal activity of human stratum corneum lipids. Arch Dermatol 1988; 124: 209-215.
7. Bibel DJ, Miller SJ, Brown BE, Pandey BB, Elias PM, Shinefield HR, Aly R. Antimicrobial activity of stratum corneum lipids from normal and essential fatty acid-deficient mice. J Invest Dermatol 1989; 92: 632-638.
8. Bibel DJ, Aly R, Shinefield HR. Antimicrobial activity of sphingosines. J Invest Dermatol 1992; 98: 269-273.
9. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
10. Leung DY. Infection in atopic dermatitis. Curr Opin Pediatr 2003; 15: 399-404.
11. Korzin BL, Leung DY, Kappler J, Marreck P. Superantigens and their potential role in human disease. Adv Immunol 1993; 54: 99-106.
12. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with staphylococcus aureus. Am J Clin Dermatol 2004; 5: 217-223.
13. Izadpanah A, Gallo RL. Antimicrobial peptides. J Am Acad Dermatol 2005; 52: 381-390.
14. Cho S-H, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to enhanced binding of staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001; 108: 269-274.
15. Murakami M, Ohtake D, Dorschner RA, Schittek B, Garbe C, Gallo RL. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 2002; 119: 1090-1092.
16. Oren A, Ganz T, Liu L, Meerloo T. In human epidermis β-defensin-2 is packed in lamellar bodies. Exp Mol Pathol 2003; 74: 180-184.
17. Braff MH, Di Nardo A, Gallo RL. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 2005; 124: 394-400.
18. Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005; 125: 9-13.
19. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414: 454-457.
20. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY. Selective killing of vaccinia virus by cathelicidin LL-37: implications for eczema vaccinatum. J Immunol 2004; 172: 1763-1767.
21. Rassner U, Feingold KR, Crumrine DA, Elias P. Coordinate assembly of lipids and enzyme proteins into lamellar bodies. Tissue & Cell 1999; 31: 489-498.
22. Schürer NY, Elias PM. The biochemistry and function of stratum corneum lipids. Adv Lipid Res 1991; 24: 27-56.
23. Fartasch M, Diepgen TL. The barrier function in atopic dry skin. Disturbance of membrane-coating granule exocytosis and formation of epidermal lipids. Acta Derm Venereol (Stockh) 1992; Suppl 176: 26-31.
24. Fartasch M. The epidermal lamellar body: a fascinating secretory organelle. J Invest Dermatol 2004; 122: 1137-1144.
25. Elias PM. Stratum corneum defense functions: an integrated view. J Invest Dermatol 2005; 125: 183-200.
26. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001; 117: 44-51.
27. Aly R, Maibach HI, Rahman R, Shinefield HR, Mandel AD. Correlation of human in vivo and in vitro cutaneous antimicrobial factors. J Infect Dis 1975; 131: 579-583.
28. Puhvel SM, Reisner RM, Amirian DA. Quantification of bacteria in isolated pilosebaceous follicles in normal skin. J Invest Dermatol 1975; 65: 525-531.
29. Schäfer L, Kragballe K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J Invest Dermatol 1991; 96: 10-15.
30. Heczko PB, Lütticken R, Hryniewicz W, Neugebauer M, Pulverer G. Susceptibility of staphylococcus aureus and Group A, B, C, and G streptococci to free fatty acids. J Clin Microbiol 1979; 9: 333-335.
31. Melnik B, Hollmann J, Plewig G. Decreased stratum corneum ceramides in atopic individuals- a pathobiochemical factor in xerosis? Br J Dermatol 1988; 119: 547-549.
32. Melnik B, Hollmann J, Hofmann U, Yuh M-S, Plewig G. Lipid composition of outer stratum corneum and nails in atopic and control subjects. Arch Dermol Res 1990; 282: 549-551.
33. Imokawa G, Abe A, Jin Y, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96: 523-526.
34. Yamamoto A, Serizawa S, Ito M, Sato Y. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991; 283: 219-223.
35. Di Nardo A, Wertz P, Gianetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78: 27-30.
36. Bleck O, Abeck D, Ring J, Hoppe U, Vietzke J-P, Wolber R, Brandt O, Schreiner V. Two ceramide subfractions detectable in Cer (AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol 1999; 113: 894-900.
37. Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omegahydroxyceramides in atopic dermatitis. J Invest Dermatol 2002; 119: 166-173.
38. Farwanah H, Raith K, Neubert RHH, Wohlrab J. Ceramide profiles of uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Arch Dermatol Res 2005; 296: 514-521.
39. Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 1991; 32: 1151-1158.
40. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM. Permeability barrier requirements regulate epidermal beta- glucocerebrosidase. J Lipid Res 1994; 35: 905-912.
41. Bowser PA, Gray PM. Sphingomyelinase in pig and human epidermis. J Invest Dermatol 1978; 70: 331-335.
42. Jensen JM, Schütze S, Förl M, Krönke M, Proksch E. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999; 104: 1761-1770.
43. Schmuth M, Man MQ, Weber F, Gao W, Feingold KR, Fritsch P, Elias PM, Holleran WM. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 2000; 115: 459-466.
44. Uchida Y, Hara M, Nishio H, Sidransky E, Inoue S, Otsuka F, Suzuki A, Elias PM, Holleran WM, Hamanaka S. Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000; 41: 2071-2082.
45. Jensen J-M, Fölster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Schütze S, Proksch E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 1423-1431.
46. Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Higuchi K, Tsuchiya T, Kawainami S, Imokawa G. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996; 106: 1242-1249.
47. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G. High expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 2000; 115: 406-413.
48. Kusuda S, Chang-Yi C, Takahashi M, Tezuka T. Localization of sphingomyelinase in lesional skin of atopic dermatitis patients. J Invest Dermatol 1998; 111: 73-738.
49. Spiegel S, Foster D, Kolesnick R. Signal transduction through lipid second messengers. Curr Opin Cell Biol 1996; 8: 159-167.
50. Geilen CG, Barz S, Bektas M. Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology. Skin Pharmacol Appl Skin Physiol 2001; 14: 261-271.
51. Arikawa J, Ishibashi M, Kawashima M, Tagaki Y, Ichikawa Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by staphylococcus aureus. J Invest Dermatol 2002; 119: 433-439.
52. Okino N, Tani M, Imayama S, Ito M. Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa. J Biol Chem 1998; 273: 14368-14373.
53. Onishi Y, Okino N, Ito M, Imayama S. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diag Laboratory Immunol 1999; 6: 101-104.
54. Wertz PW, Downing DT. Free sphingosines in human epidermis. J Invest Dermatol 1990; 94: 159-161.
55. Wertz PW, Downing DT. Free sphingosines in porcine epidermis. Biochim Biophys Acta 1989; 1002: 213-217.
56. Stewart ME, Downing DT. Free sphingosines of human skin include 6-hydroxysphingosine and unusually long-chain dihydrosphingosines. J Invest Dermatol 1995; 105: 613-618.
57. Ohta H, Ruan F, Hakomori S, Igarashi Y. Quantification of free sphingosine in cultured cells by acylation with radioactive anhydride. Anal Biochem 1994; 222: 489-494.
58. Bibel DL, Miller SJ, Brown BE, Pandey BB, Elias PM, Shinefield HR, Aly R. Antimicrobial activity of stratum corneum lipids from normal and essential fatty acid-deficient mice. J Invest Dermatol 1989; 92: 632-638.
59. Bibel DJ, Aly R, Shah S, Shinefield HR. Sphingosines: antimicrobial barriers of skin. Acta Derm Venereol (Stockh) 1993; 73: 407-411.
60. Bibel DJ, Aly R, Shinefield HR. Inhibition of microbial adherence by sphinganine. Can J Microbiol 1992; 38: 383-385.
61. Bibel DJ, Aly R, Shinefield HR. Topical sphingolipids in antisepsis and antifungal therapy. Clin Exp Dermatol 1995; 20: 395-400.
62. Downing DT, Dose RW, Abraham W. Interaction between sphingosine and cholesterol sulphate in epidermal lipids. J Lipid Res 1993; 34: 563-569.
63. Payne CD, Ray TL, Downing DT. Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro. J Invest Dermatol 1996; 106: 549-552.
64. Garg SK, Volpe E, Palmieri G, Mattei M, Galati D, Martino A, Piccioni MS, Valente E, Bonanno E, De Vito P, Baldini PM, Spagnoli LG, Colizzi V, Fraziano M. Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo. J Infect Dis 2004; 189: 2129-2138.
65. Hachem J-P, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121: 345-353.
66. Fluhr JW, Elias PM. Stratum corneum pH: formation and function of the "acid mantle". Exog Dermatol 2002; 1: 163-175.
67. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis. Impact on skin barrier function and colonization with staphylococcus aureus. Am J Clin Dermatol 2004; 5: 217-223.
68. Rippke F, Schreiner V, Schwanitz H-J. The acidic milieu of the horny layer. New findings on the physiology and pathophysiology of skin pH. Am J Clin Dermatol 2002; 3: 261-272.
69. Mempel M, Lina G, Hojka M, Schnopp C, Seidel HP, Schafer T, Ring J, Vandenesch F, Abeck D. High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema. Eur J Clin Microbiol Infect Dis 2003; 22: 306-309.
70. Ou L-S, Goleva E, Hall C, Leung DYM. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004; 113: 756-763.
71. Wefers H, Melnik BC, Flür M, Bluhm C, Lehmann P, Plewig G. Influence of UV irradiation on the composition of human stratum corneum lipids. J Invest Dermatol 1991; 96: 959-962.
72. Lehmann P, Melnik B, Hölzle E, Neumann N, Plewig G. Zur Wirkung von UV-A- und UV-B-Bestrahlungen auf die Hautbarriere. Hautarzt 1992; 43: 344-351.
73. McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005; 125: 1-8.
74. Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005; 125: 9-13.
75. Ishida-Yamamoto A, Simon M, Kishibe M, Miyauchi Y, Takahashi H, Yoshida S, O'Brien TJ, Sere G, Izuka H. Epidermal lamellar granules transport different cargoes as distinct aggregates. J Invest Dermatol 2004; 122: 1137-1144.